How has Collegium Pharmaceutical, Inc.'s non-cash lease benefit changed year-over-year?

Collegium Pharmaceutical, Inc.'s non-cash lease benefit decreased by 203.3% year-over-year, from -$30K to -$91K.

What does non-cash lease benefit mean?

Represents the non-cash portion of operating lease expenses recognized in the income statement that does not impact cash flow. This adjustment is necessary to reconcile net income to net cash provided by operating activities by removing non-cash accounting entries related to lease obligations.

Collegium Pharmaceutical, Inc. COLL Non-cash lease benefit

Non-cash lease benefit at other companies

JAN

Janus Living JAN

$47K—

Adaptive BiotechnologiesADPT

$1.45M+10.5%

PROG HoldingsPRG

-$732K+28.6%

Kestra Medical Technologies, Ltd. Common StockKMTS

$125K+42.0%

VeracyteVCYT

$732K-19.0%

Kohl'sKSS

$22M+4.8%

Other financials

Income statement

See full

Revenue$193.5M+8.9%

Gross profit$117.2M+20.5%

Operating income$30.9M+42.5%

Net income$14.5M+500%

EPS (diluted)$0.40+471%

Balance sheet

See full

Cash & equivalents$289.6M+147%

Total debt$5.2M-19.5%

Total equity$312.4M+33.3%

Total assets$1.7B+1.3%

Cash flow

See full

Operating cash flow$57.1M+3.1%

CapEx$270.0K-66.2%

Free cash flow$56.8M+4.1%

Valuation

See full

Market cap$1.15B+17.9%

Enterprise value$869.67M-0.3%

P/E15.4×-6.9×

P/S1.5×0.0×

Profitability

See full

Gross margin60.7%+3.0pp

Operating margin23.7%+2.3pp

Net margin9.4%+2.8pp

FCF margin41.4%+10.4pp

Returns & leverage

See full

Return on equity27.4%+8.2pp

Debt / equity0×0.0×

Current ratio1.7×+0.6×

Where this comes from

Reported directly by Collegium Pharmaceutical, Inc. in its filing.

Tagged under the XBRL concept coll:OperatingLeasePaymentsNonCash.

The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Collegium Pharmaceutical, Inc.'s non-cash lease benefit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Collegium Pharmaceutical, Inc.'s non-cash lease benefit?: Collegium Pharmaceutical, Inc. (COLL) reported non-cash lease benefit of -$91K in Q1 2026.
How has Collegium Pharmaceutical, Inc.'s non-cash lease benefit changed year-over-year?: Collegium Pharmaceutical, Inc.'s non-cash lease benefit decreased by 203.3% year-over-year, from -$30K to -$91K.
What does non-cash lease benefit mean?: Represents the non-cash portion of operating lease expenses recognized in the income statement that does not impact cash flow. This adjustment is necessary to reconcile net income to net cash provided by operating activities by removing non-cash accounting entries related to lease obligations.